Skip to main content
. 2021 Oct;10(10):3995–4011. doi: 10.21037/tlcr-21-767

Figure 6.

Figure 6

The expression level of USP5 and CCND1 is a negative index for patient survival in lung adenocarcinoma (LUAD) tissues. (A) Correlation of the mRNA level of USP5 with the prognosis of LUAD patients. *, P<0.05, Log-rank test. The original data were obtained from UALCAN database (http://ualcan.path.uab.edu/). (B) Correlation of the protein level of USP5 with the prognosis of LUAD patients. ***, P<0.001, Log-rank test. The original data were obtained from The Human Protein Atlas (THPA) database (https://www.proteinatlas.org/). (C) Correlation of the mRNA level of CCND1 with the prognosis of LUAD patients. The original data were obtained from UALCAN database. (D) Correlation of the protein level of CCND1 with the prognosis of LUAD patients. *, P<0.05, Log-rank test. The original data were obtained from THPA database. All patients were classified into two groups based on the mRNA or protein expression level of USP5 or CCND1.